Related references
Note: Only part of the references are listed.Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis
Benedikt Schoser et al.
JOURNAL OF NEUROLOGY (2017)
European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience
A. T. van der Ploeg et al.
EUROPEAN JOURNAL OF NEUROLOGY (2017)
Search for Pompe disease among patients with undetermined myopathies
C. Lindberg et al.
ACTA NEUROLOGICA SCANDINAVICA (2016)
Response of 33 UK patients with infantile-onset Pompe disease to enzyme replacement therapy
A. Broomfield et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2016)
Prevalence of Pompe disease in 3,076 patients with hyperCKemia and limb-girdle muscular weakness
Zoltan Lukacs et al.
NEUROLOGY (2016)
Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment
Federica Montagnese et al.
JOURNAL OF NEUROLOGY (2015)
Delayed diagnosis of late-onset Pompe disease in patients with myopathies of unknown origin and/or hyperCKemia
Jordi Perez-Lopez et al.
MOLECULAR GENETICS AND METABOLISM (2015)
ELECTROMYOGRAPHIC FINDINGS IN 37 PATIENTS WITH ADULT-ONSET ACID MALTASE DEFICIENCY
Charles D. Kassardjian et al.
MUSCLE & NERVE (2015)
Targeted screening for the detection of Pompe disease in patients with unclassified limb-girdle muscular dystrophy or asymptomatic hyperCKemia using dried blood: A Spanish cohort
E. Gutierrez-Rivas et al.
NEUROMUSCULAR DISORDERS (2015)
Screening for late-onset Pompe disease in Finland
Johanna Palmio et al.
NEUROMUSCULAR DISORDERS (2014)
Swiss national guideline for reimbursement of enzyme replacement therapy in late-onset Pompe disease
Thomas Hundsberger et al.
JOURNAL OF NEUROLOGY (2013)
Late-onset Pompe disease is prevalent in unclassified limb-girdle muscular dystrophies
Nicolai Preisler et al.
MOLECULAR GENETICS AND METABOLISM (2013)
Screening for later-onset Pompe's disease in patients with paucisymptomatic hyperCKemia
Marco Spada et al.
MOLECULAR GENETICS AND METABOLISM (2013)
Toward deconstructing the phenotype of late-onset Pompe disease
Angela Schüller et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2012)
Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria
Thomas P. Mechtler et al.
LANCET (2012)
A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations
Andreas Herzog et al.
ORPHANET JOURNAL OF RARE DISEASES (2012)
Effect of enzyme therapy and prognostic factors in 69 adults with Pompe disease: an open-label single-center study
Juna M. de Vries et al.
ORPHANET JOURNAL OF RARE DISEASES (2012)
Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational study
Nadine A. M. E. van der Beek et al.
ORPHANET JOURNAL OF RARE DISEASES (2012)
The clinical and electrodiagnostic characteristics of Pompe disease with post-enzyme replacement therapy findings
Lisa D. Hobson-Webb et al.
CLINICAL NEUROPHYSIOLOGY (2011)
A Randomized Study of Alglucosidase Alfa in Late-Onset Pompe's Disease.
Ans T. van der Ploeg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Lysosomal storage disease 2 - Pompe's disease
Ans T. van der Ploeg et al.
LANCET (2008)
Clinical features of late-onset Pompe disease: A prospective cohort study
John H. J. Wokke et al.
MUSCLE & NERVE (2008)
Late onset Pompe disease:: Clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients
Wolfgang Muller-Felber et al.
NEUROMUSCULAR DISORDERS (2007)
The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature
HMP van den Hout et al.
PEDIATRICS (2003)
Juvenile and adult-onset acid maltase deficiency in France -: Genotype-phenotype correlation
P Laforêt et al.
NEUROLOGY (2000)